Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241604 · ClinicalTrials.gov registry record · NA
Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device
A NA study, sponsored by Philips Respironics.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01241604 is a NA study that was terminated before completion, run by Philips Respironics. The registered enrollment target is 11 participants.
The verdict
NCT01241604, a NA study, was terminated before completion, sponsored by Philips Respironics.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study is being undertaken to collect data from Respironics, Inc's BiPAP autoSV3 and compare with data from Respironics, Inc's BiPAP S/T device, to confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat participants experiencing Comp SAS no worse than the BiPAP S/T device. This will be determined using a comparative, randomized design with the participants blinded to the therapy. Additionally, attempts will be made to blind the central scorer(s) with respect to which device is in use.
Interventions
- DEVICE BiPAP S/T
- DEVICE BiPAP Auto SV3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01241604
The ClinicalTrials.gov registry entry for NCT01241604 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BiPAP S/T is the first listed.
NCT01241604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01241604 about?
NCT01241604 is a clinical study titled "Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device". This study is being undertaken to collect data from Respironics, Inc's BiPAP autoSV3 and compare with data from Respironics, Inc's BiPAP S/T device, to confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat participants experiencing Comp SAS no worse than the BiPAP ...
What is the current status of trial NCT01241604?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2009-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT01241604?
The interventions under investigation include: BiPAP S/T (DEVICE), BiPAP Auto SV3 (DEVICE).
Who is sponsoring clinical trial NCT01241604?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.